Pedaling away chemo pain: new study tests cycling as a remedy for nerve damage

NCT ID NCT07150117

Recruiting now Symptom relief Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a 12-week supervised cycling program can reduce nerve pain and improve quality of life in 30 adults who have had chemotherapy for cancer. Participants will ride a stationary bike twice a week for up to an hour. The main goal is to see if people find the program acceptable and if a larger trial is worth doing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: supervised stationary cycling exercise program
What this could lead to: If it works, this could point toward a simple, drug-free way to reduce nerve pain and improve daily function for cancer survivors.
What could go wrong: This is a very small, early proof-of-concept study with only 30 people. It is designed to see if a larger trial is even possible, not to prove the exercise works. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer chemotherapy-induced neuropathy Motor Activity neoplasm peripheral nervous system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADULTS CANCER

Contacts and locations

Locations

Cross Cancer Institute
RECRUITING

Edmonton, Alberta, T6G 1Z2, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.